DEA Issues Final Rule Up-Scheduling Hydrocodone Combination Products from Schedule III to Schedule II

more+
less-

On August 22, 2014, the Drug Enforcement Administration (DEA) published a final rule upscheduling hydrocodone combination products (HCPs) under the Controlled Substances Act (CSA) from Schedule III to Schedule II.

The entities and individuals who handle or prescribe HCPs have only 45 days—until October 6, 2014—to come into full compliance with the increased regulatory controls that apply to Schedule II substances.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Controlled Substances Act, DEA, Final Rules, Prescription Drugs

Published In: Administrative Agency Updates, Health Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »